- Home
- BHP vs GILD Comparison
BHP vs GILD Comparison
Compare BHP & GILD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHP
- GILD
- Stock Information
- Founded
- BHP 1851
- GILD 1987
- Country
- BHP Australia
- GILD United States
- Employees
- BHP N/A
- GILD N/A
- Industry
- BHP Metal Mining
- GILD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BHP Basic Materials
- GILD Health Care
- Exchange
- BHP Nasdaq
- GILD Nasdaq
- Market Cap
- BHP 125.3B
- GILD 113.0B
- IPO Year
- BHP 1987
- GILD 1992
- Fundamental
- Price
- BHP $50.06
- GILD $91.84
- Analyst Decision
- BHP Strong Buy
- GILD Buy
- Analyst Count
- BHP 3
- GILD 26
- Target Price
- BHP $53.00
- GILD $98.17
- AVG Volume (30 Days)
- BHP 2.2M
- GILD 6.6M
- Earning Date
- BHP 02-18-2025
- GILD 02-11-2025
- Dividend Yield
- BHP 5.83%
- GILD 3.35%
- EPS Growth
- BHP N/A
- GILD N/A
- EPS
- BHP 1.55
- GILD 0.10
- Revenue
- BHP $56,027,000,000.00
- GILD $28,299,000,000.00
- Revenue This Year
- BHP N/A
- GILD $6.50
- Revenue Next Year
- BHP N/A
- GILD $0.36
- P/E Ratio
- BHP $16.06
- GILD $908.39
- Revenue Growth
- BHP 3.40
- GILD 3.31
- 52 Week Low
- BHP $48.06
- GILD $62.07
- 52 Week High
- BHP $63.21
- GILD $98.90
- Technical
- Relative Strength Index (RSI)
- BHP 50.08
- GILD 51.58
- Support Level
- BHP $49.01
- GILD $90.82
- Resistance Level
- BHP $50.17
- GILD $93.07
- Average True Range (ATR)
- BHP 0.65
- GILD 1.54
- MACD
- BHP 0.29
- GILD -0.03
- Stochastic Oscillator
- BHP 82.34
- GILD 56.28
About BHP BHP Group Limited (Each representing two)
BHP is a global diversified miner mainly supplying iron ore and copper. The merger of BHP Limited and Billiton PLC created the present-day BHP Group. The dual-listed structure from the 2001 BHP and Billiton merger was collapsed in 2022. Major assets include Pilbara iron ore and Escondida copper. Onshore US oil and gas assets were sold in 2018 and the remaining Petroleum assets were spun off and merged with Woodside in 2022, with BHP vesting the Woodside shares it received to BHP shareholders. It purchased copper miner Oz Minerals in fiscal 2023 and is entering the potash market through the development of its Jansen project in Canada. However, due to low nickel prices, BHP placed its nickel business on care and maintenance in 2024.
About GILD Gilead Sciences Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).